New research reveals that individuals who stop using blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover lost weight far faster than those who end traditional lifestyle regimens.
Published data in a prominent health publication demonstrates that while overweight people can lose about a fifth of their total mass while on the medication, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"People using these medications must be informed of the potential of rapid weight regain when the medication concludes," stated researcher Dr. Susan Jebb.
That rate of recovery means a reversion to original weight in about one and a half years.
Comparing Treatments
The study, which reviewed 37 of trials involving thousands of patients, compared the results of these new drugs with older methods.
The team note that people who shed pounds through dieting generally have a more gradual weight regain—around 100 grams monthly—once they finish.
Explaining the Rapid Regain
Doctors propose the mechanism of the jabs accounts for the amplified weight return.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls appetite.
"Artificially providing the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement results in hunger is uncontrolled, making excessive eating far more likely."
A Chronic Disease?
Medical guidelines advise the jabs for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, due to the significant potential of weight regain, the treatment might need to be long-term.
This opinion is echoed by pharmaceutical companies, who say that the results "emphasize the chronic nature of obesity," similar to managing conditions like high blood pressure.
Patient Testimonies
People who have stopped the medication explain a intense resurgence of hunger.
"I experienced a switch that goes on and I was suddenly ravenous," described an individual.
This difficulty is compounded if patients have not adopted lasting lifestyle or habit changes during therapy.
Significant Use
Survey data show that a significant number of adults in the UK have used these injections in the last 12 months, with desire remaining high.
- Use is higher among females than men.
- The middle-aged age group shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than public health services.
Ultimately, experts emphasize that while the jabs are powerful agents for weight loss, they are not a magic fix and lasting health benefits hinges on integrated behavioural management.
